-
Imagine being in the position of publicly critiquing a competing hospital's compliance with Joint Commission requirements. Would you be able to be completely objective? Even if you were, would your colleagues really trust your ability to be impartial?
-
Just 14 weeks after The Joint Commission approved an interim action that allowed pharmacists to retrospectively review ED medication orders to comply with element of performance (EP) 1 for standard 4.10 of medication management, the action was suspended.
-
U.S. HIV providers are bracing themselves for a flood of new HIV patients as hospitals and many doctors respond to the new recommendations by the Centers for Disease Control and Prevention (CDC) of Atlanta, GA, to provide opt-out HIV testing to nearly every patient they see.
-
The Food and Drug Administration (FDA) is warning healthcare professionals regarding the significantly increased risk for serious and life-threatening cardiovascular (CV) complications associated with normalization of hemoglobin levels in patients receiving erythropoiesis-stimulating agents (ESAs).
-
Since 1995, the outlook for patients with HIV infection has improved significantly with the advent of triple-drug-potent antiretroviral (ARV) therapy regimens.
-
Three years of experience using the rapid HIV test have shown New Jersey public health officials that using the rapid test is preferred by clients, and the results are reliable, a recent study shows.
-
HIV clinicians and researchers still are learning how HIV evolves through mutations and development of resistance. If patterns of increasing resistance emerge then this has serious implications for HIV treatment and prevention.
-
Major revisions to the Centers for Disease Control and Prevention (CDC) guidelines for HIV screening are either a boon to the task of identifying the 250,000 Americans who carry the virus but don't know it or a blow to patient autonomy and privacy.
-
The AIDS global epidemic continues to grow, and some countries are seeing a resurgence of infection rates, according to the annual epidemic update by the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Health Organization (WHO) in Geneva, Switzerland.
-
The President's Emergency Plan for AIDS Relief (PEPFAR) has resulted in $15 billion to be spent in 15 focus countries, with smaller amounts going to more than 100 other countries.
